Data compiled by Redley Lamar · ChainSifter Intelligence
7Suppliers
8Customers
3Debt Items
6Related Chains
Source-Backed Evidence Depth
Lifeward Ltd. (LFWD) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
22Total relationships
4Distinct source URLs
17High confidence
0.826Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Lifeward Ltd. Suppliers
Ticker
Name
Confidence
Evidence
ORATECH-PHARMA-INC
ORATECH-PHARMA-INC
92%
Share Purchase Agreement, dated as of January 12, 2026, by and among the Company and Oratech Pharma, Inc. and Oramed
Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD graph: Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD graph: Proposal No. 1: To approve the Comp…
Proposal No. 1: To approve the Company's issuance of Ordinary Shares, as described in the Proxy Statement, (a) to Oramed, as consideration for the acquisition of 100% of the outstanding shares of Ora…
ORATECH-LTD
ORATECH-LTD
90%
the rights and obligations of Oratech Pharma under the Share Purchase Agreement were assigned to Oratech Ltd.
ORATECH-PHARMA
ORATECH-PHARMA
90%
Oratech Pharma transferred and assigned all of its rights, title and interest under the Share Purchase Agreement to Oratech
CIRTRONICS
CIRTRONICS
85%
We also rely on third-party suppliers, many of which contract directly with Cirtronics, to supply certain components of our products
ORAMED
ORAMED
80%
The Subsequent Secured Promissory Note contains customary representations, warranties and covenants limiting additional indebtedness, liens, guaranties, mergers and consolidations, substantial asset …
Lifeward Ltd. Customers
Ticker
Name
Confidence
Evidence
ORATECH-PHARMA-INC
ORATECH-PHARMA-INC
92%
Proposal No. 1: To approve the Company's issuance of Ordinary Shares, as described in the Proxy Statement, (a) to Oramed, as consideration for the acquisition of 100% of the outstanding shares of Ora…
Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD graph: Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD graph: Reciprocal relationship from ORMP g…
ORAMED
ORAMED
85%
the Company entered into a securities purchase agreement with Oramed, certain investors and Oramed, as collateral agent
the Company issued $10,000,000.00 aggregate principal amount senior secured convertible notes
BTL-INDUSTRIES
BTL-INDUSTRIES
62%
ecember 31, 2024. We estimate the installed base of AlterG systems is over 6,000 installed units worldwide as of December 31, 2025. With the finalization of the Medicare payment rates for exoskeleton…
CAPITAL-RESOURCES
CAPITAL-RESOURCES
62%
Item 1A. Risk Factors — Risks Related to Our Business and Our Industry — Our future growth and operating results will depend on our ability to develop, receive regulatory clearance for, and commercia…
CORLIFE-LLC
CORLIFE-LLC
62%
signs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical setti…
ORAMED-PHARMACEUTICALS-INC
ORAMED-PHARMACEUTICALS-INC
62%
Neuro integrates advanced technologies and therapies to support individuals with neurological injuries. We believe this agreement will expand access to the ReWalk Personal Exoskeleton in additional i…
Lifeward Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
LFWD-DEBT-10676
Warrants outstanding: 513930
90%
xbrl warrant detail from xbrl 2025-12-31.
LFWD-DEBT
Debt stack $3.4M
90%
Market cache reports total debt of $3.4M.
LFWD-DEBT-10677
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2015-12-31.
Lifeward Ltd. Acquisitions
Acquired Entity
Name
Confidence
Evidence
LFWD-ACQ-0001178913-26-001724
The Company issued 1,296,296 warrants to purchase Ordinary Shares as part of the acquisition of ...
85%
The Company issued 1,296,296 warrants to purchase Ordinary Shares as part of the acquisition of Oratech Pharma.
LFWD-ACQ-0001178913-26-000244
The Company intends to issue ordinary shares to Oramed as consideration for the acquisition of 1...
85%
The Company intends to issue ordinary shares to Oramed as consideration for the acquisition of 100% of the outstanding shares of Oratech.
LFWD-ACQ-0001178913-26-000642
Lifeward Ltd. will issue ordinary shares as part of the consideration for acquiring assets from ...
85%
Lifeward Ltd. will issue ordinary shares as part of the consideration for acquiring assets from Skelable Ltd.
LFWD-ACQ-0001178913-26-000875
Approval for the issuance of Ordinary Shares to Oramed Pharmaceuticals Inc. as consideration for...
85%
Approval for the issuance of Ordinary Shares to Oramed Pharmaceuticals Inc. as consideration for the acquisition of 100% of the outstanding shares of Oratech Pharma, Inc.
Lifeward Ltd. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Lifeward Ltd..
